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Paraplegia is a serious complication after recon-
structive operation for a descending thoracic or tho-
racoabdominal aortic aneurysm. To prevent such
neurologic damage, circulatory assist with distal
aortic perfusion and partial bypass or temporary
aortofemoral bypass is performed to maintain per-
fusion of the spinal cord.1 However, the incidence
of paraplegia after these bypass procedures has been
reported to range from 8% to 25%.2,3
Recently, various pharmacologic interventions
for spinal cord protection have been used both
clinically and experimentally.4,5 Prostaglandin E1
(PGE1) is known to play an important role in pro-
tecting cells from hypoxemia.6 PGE1 protects the
cells by inducing precapillary sphincter relaxation
and increasing the supply of oxygen and glucose to
the cells, as well as through inhibition of postis-
chemic release of lysosomal enzymes.7 In this
study, we perfused the intercostal arteries of dogs
with oxygenated blood containing PGE1 and eval-
uated the protective effect against spinal cord
ischemia by measuring the sensory evoked spinal
potential (SESP).
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Purpose: A new protective method against the spinal cord ischemia that occurs during
aortic clamping was investigated in dogs. Oxygenated blood containing prostaglandin
E1 (PGE1) was administered at the clamped aortic segment, and the effect was evaluat-
ed by measurement of the sensory evoked spinal potential (SESP).
Methods: In 30 dogs, a thoracotomy was made with dissection of the thoracic aorta. After
intravenous heparin (100 units/kg) was administered, the proximal and distal descend-
ing thoracic aortas were cross-clamped for 60 minutes. Group A (n = 10) received oxy-
genated blood at the rate of 1.0 ml/kg/min. Groups B (n = 10) and C (n = 10) received
oxygenated blood at the same rate, with PGE1 at the dosage of 25 and 50 ng/kg/min,
respectively. The infusion was continuously administered throughout the entire period of
ischemia. SESP was measured with epidural electrodes before clamping, 10 and 60 min-
utes after clamping, and 10 and 60 minutes after declamping. Neurologic outcome was
assessed at 24 hours after the operation and graded according to the method of Tarlov.
Results: There was no significant hemodynamic change in any group. At 60 minutes after
clamping and at 10 and 60 minutes after declamping, the amplitude of SESP was lower than
that at preclamping in groups A and B (p < 0.05). At 60 minutes after clamping and at 10
and 60 minutes after declamping, the SESP was more markedly decreased in group A com-
pared with groups B and C. Regarding postoperative neurologic outcome, the dogs with
SESP amplitude of more than 50% of the preclamping control value at 60 minutes after
clamping showed neither paralysis nor paraplegia. Seven of nine dogs with less than 50%
SESP amplitude showed neurogenic deficit. In a comparison of groups A, B, and C, the
Tarlov score for group A dogs was significantly lower than that for group C dogs (p < 0.05). 
Conclusion: In this model, PGE1 administration at the rate of 50 ng/kg/min showed
sufficient spinal cord protection against ischemia without a decrease in the blood pres-
sure. Further studies are needed to determine the dose that will provide the maximal
protective effect and to determine the maximum duration of ischemia against which
PGE1 shows protective effects. (J Vasc Surg 1998;28:301-7.)
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MATERIALS AND METHODS
Animal preparation. Thirty mongrel dogs
(weight range, 7.9 to 10.2 kg) were used in this study.
Anesthesia was induced with intramuscular injection
of ketamine HCl (2 mg/kg). Ventilation with 60%
oxygen and 40% N2O was provided through a cuffed
endotracheal tube. A Harvard ventilator (Harvard
Apparatus, South Natick, Mass.) was used to deliver a
minute volume of 250 ml/kg. A single catheter was
placed in a right foreleg peripheral vein for the intra-
venous infusion of 5% glucose solution to maintain the
systemic blood pressure. The blood was withdrawn for
serum blood sugar measurement before, during, and
after clamping, and the rectal temperature was mea-
sured continuously with a thermometer (HL200;
Anritsu, Tokyo, Japan). All of the dogs received
humane care in compliance with the Guide for the
Care and Use of Laboratory Animals (National
Institutes of Health, Bethesda, Md.) and the
Guideline for the Care and Use of Laboratory Animals
(Kanazawa University, Takara-machi Campus).
In dogs in the prone position, a thoracotomy was
performed via the left sixth intercostal space with
dissection of the thoracic aorta 1 cm distal to the ori-
gin of the left subclavian artery for proximal clamp-
ing. Dissection of the thoracic aorta 1 cm proximal
to the origin of the celiac artery was performed for
distal clamping. Aortofemoral shunting was per-
formed using a temporary bypass from the left sub-
clavian artery to the left common femoral artery.
Cannulation of the clamped segment was performed
with a 16-gauge catheter. The proximal arterial pres-
sure was monitored at the aortic arch (Fig. 1, P-1),
and the distal arterial pressure was monitored at the
right common femoral artery (Fig. 1, P-2). 
SESP recording. In dogs in the prone position,
two 18-gauge polyethylene needles were inserted
into the epidural space at the lower thoracic and
lumbar vertebral levels. Two tubular bipolar elec-
trodes (IMC-KG-102; Nihon Kohden, Tokyo,
Japan) were inserted into the epidural space through
these needles. The tip of the recording electrode was
placed at the cervical spinal level, and the tip of the
stimulating electrode was placed at the lumbar spinal
level. The distance between the recording and the
stimulating electrodes was 10 cm. SESP was elicited
and recorded using a computer (MEM7202; Nihon
Kohden). Square-wave pulses of 0.01-msec duration
and supramaximal intensity (10 to 20 mA) were
generated at the rate of 10 to 20 per second. The
recorded potentials were amplified, filtered (20 to
2000 Hz), and averaged for a minimum of 100
impulses per recording. The recorded data were ana-
lyzed for peak-to-peak amplitude, onset latency, and
time until return to baseline with reperfusion.
Clamping. After intravenous heparin (100
units/kg) was administered, the proximal and distal
descending thoracic aortas were cross-clamped for
60 minutes. An 18-gauge plastic needle was inserted
into the clamped aortic segment for regional injec-
tion of oxygenated blood with or without PGE1.
Perfusion rate. After the proximal and distal
clamping, the amount of backflow from the clamped
segment was measured; the mean amount was 0.72
± 0.35 ml/kg. Accordingly, we selected the perfu-
sion rate of 1.0 ml/kg, which exceeded the back-
flow. The temperature of the perfusate was main-
tained at 30° to 35°C. 
Pharmaceutical agents. PGE1 (alprostadil) was
purchased from Ono Yakuhin Kougyou (Osaka,
Japan). The stability of this PGE1 at the purity of
99.0% when stored at less than 25° C for 12 months
has been confirmed through the use of high-perfor-
mance liquid chromatography.
Groups. The dogs were divided into three
groups: group A (n = 10) received oxygenated blood
at a rate of 1.0 ml/kg/min; group B (low-dose
PGE1 perfusion group, n = 10) received oxygenated
blood (also at 1.0 ml/kg/min) with PGE1 at a
dosage of 25 ng/kg/min; and group C (high-dose
PGE1 perfusion group, n = 10) received oxygenated
blood (also at 1.0 ml/kg/min) with PGE1 at a
dosage of 50 ng/kg/min. The infusion was started at
the same time as the cross-clamping and was main-
tained for the entire 60 minutes until declamping. 
Hemodynamics and SESP change. The heart
rate and proximal systolic blood pressure were mea-
sured before clamping as a control measurement, at
30 minutes after clamping, and at 30 minutes after
declamping. The distal systolic arterial pressure was
maintained at 70 and 100 mm Hg. SESP was mea-
sured before clamping as a control measurement, at
10 and 60 minutes after clamping was initiated, and
at 10 and 60 minutes after declamping (Fig. 2).
Neurologic outcome. After the dogs woke up,
the tracheal tube was removed, and neurologic
assessment of the hindlimbs was performed.
Neurologic deficit was graded by investigators
who were not blinded with regard to the experi-
mental protocol. Neurologic outcome was assessed
24 hours after the operation and graded according
to the method of Tarlov, in which 0 indicates no
movement of the hindlimbs, 1 indicates perceptible
movement of the joints of the hindlimbs, 2 indi-
cates good movement but the inability to stand, 3
indicates the ability to stand and walk, and 4 indi-
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cates a complete recovery.8 Animals with scores of 0
were paraplegic, and those with scores of 1 to 3
were paralytic.
Statistical analysis. All results are presented as
mean ± SD. Comparisons of blood pressure, heart
rate, and SESP were made using an analysis of vari-
ance and Fisher’s post-hoc testing. Significance was
defined at a level of p < 0.05. All analyses were per-
formed using StatView, Version 4.0, for Macintosh
(Abacus Concepts, Berkeley, Calif.).
RESULTS
None of the dogs died during the operation. The
anal temperature of all dogs was 35.4° to 37.2° C,
and the blood sugar level was 86 to 156 mg/dl.
Hemodynamic Change
There was no cardiac event during clamping and
no significant change in blood pressure or heart rate
in groups A, B, and C (Tables I and II). 
SESP Change
Group A. A normal amplitude (greater than
80% of preclamping amplitude) of SESP was
observed in 3 of 10 dogs at 10 minutes after clamp-
ing, 2 dogs at 60 minutes after clamping, 2 dogs at
10 minutes after declamping, and 4 dogs at 60 min-
utes after declamping. The amplitude of SESP at
these times was 65% ± 27%, 41% ± 36%, 56% ± 39%,
and 54% ± 40%, respectively (Fig. 3). The amplitude
of SESP at all four times after clamping or declamp-
Fig. 1. Experimental design of a canine model. Aortofemoral shunting is performed by use of
a temporary bypass. Proximal (P-1) and distal (P-2) arterial pressure monitorings are per-
formed. Blood with or without PGE1 is injected into the clamped aortic segment. The tem-
perature of this perfusate was maintained at 30° to 35°C. 
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ing was significantly decreased compared with that
before clamping (p < 0.01). 
Group B. A normal amplitude of SESP was
observed in 4 dogs at 10 minutes after clamping, 4
dogs at 60 minutes after clamping, 5 dogs at 10 min-
utes after declamping, and 5 dogs at 60 minutes after
declamping. The amplitude of SESP at these times
was 79% ± 29%, 71% ± 30%, 71% ± 37%, and 69% ±
38%, respectively (Fig. 3). The amplitude of SESP at
each of the four times was significantly decreased
compared with that before clamping (p < 0.05). 
Group C. A normal amplitude of SESP was
observed in 4 dogs at 10 minutes after clamping, 7
dogs at 60 minutes after clamping, 7 dogs at 10 min-
utes after declamping, and 7 dogs at 60 minutes after
declamping. The amplitude of SESP at these times
was 75% ± 27%, 80% ± 15%, 93% ± 20%, and 90% ±
16%, respectively (Fig. 3). Only the amplitude at 10
minutes after clamping was significantly decreased
compared with that at preclamping (p < 0.01). 
Comparisons among groups. At 10 minutes
after clamping, there were no significant differences
in SESP among groups A, B, and C. At 60 minutes
after clamping and at 10 and 60 minutes after
declamping, the SESP in group A was significantly
lower than that in groups B and C (p < 0.05).
Neurologic Outcome
In all groups, the dogs with SESP amplitude of
greater than 50% at 60 minutes after clamping
showed neither paralysis nor paraplegia (Table III).
Group A. The Tarlov score for all 10 dogs was
2.7 ± 1.8 (mean ± SD). Five of the dogs showed
SESP amplitude of less than 50% at 60 minutes after
clamping. The postoperative neurologic deficit was
noted in four dogs, paralysis in two (Tarlov score,
0), and paraplegia in two (Tarlov score, 1 and 2).
One dog showed no neurologic deficit. 
Group B. The Tarlov score for all 10 dogs was
3.5 ± 1.1. Three of the dogs showed SESP ampli-
tude of less than 50% at 60 minutes after clamping.
Postoperative neurologic deficit was observed in two
dogs, paralysis in one (Tarlov score, 0), and paraple-
gia in one (Tarlov score, 2). One dog showed no
neurologic deficit.
Group C. The Tarlov score for all 10 dogs was
3.9 ± 0.3. One dog with an SESP amplitude of less
than 50% at 60 minutes after clamping showed
paralysis (Tarlov score, 3) after operation.
Fig. 2. Change in SESP. The SESP of a dog is shown
before clamping as a control (a), 10 minutes (b) and 60
minutes (c) after clamping was initiated, and 10 minutes
(d) and 60 minutes (e) after declamping.
Table I. Change in blood pressure
Blood pressure (mm Hg)
During After 
Preclamping clamping declamping
Group A 121 ± 25 103 ± 16 118 ± 24 NS
Group B 112 ± 28 100 ± 29 120 ± 26 NS
Group C 116 ± 19 109 ± 21 120 ± 16 NS
NS, not significant.




Group A 98 ± 26 100 ± 13 131 ± 24 NS
Group B 122 ± 10 123 ± 13 118 ± 24 NS
Group C 118 ± 18 110 ± 22 134 ± 26 NS
NS, not significant.
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Regarding neurologic outcome, the Tarlov score
in group A dogs was lower level than that in group
C dogs (p < 0.05).
DISCUSSION
Paraplegia is a major operative complication after
repair of the descending thoracic aorta. Aortic cross-
clamping and transaction or exclusion of intercostal
vessels can cause inadequate spinal cord perfusion
during surgery. Various techniques to prevent spinal
cord injury, including shunting, partial bypass,
drainage of cerebrospinal fluid, hypothermia, and
pharmacologic interventions, have been used both
clinically and experimentally.3-7,9-13 However, para-
plegia is reported to occur in 8% to 25% of patients
undergoing this type of bypass.2,3 Paraplegia
remains a risk with this type of surgery. Whether
these methods prevent ischemic spinal cord damage
remains controversial. Our recent method of
attempting to prevent spinal cord ischemia involves
perfusion of the critical intercostal arteries with oxy-
genated normothermic blood (rate, 80 ml/min) and
reimplantation of these arteries.13 Oxygenated
blood is supplied to the distal aorta and critical inter-
Fig. 3. SESP amplitude at each period. Data are expressed as mean ± SD. *p < 0.05 compared
with preclampimg SESP.     p < 0.05 compared among groups A, B, and C. NS, not significant.
Table III. Neurologic outcome
SESP amplitude
Neurologic outcome
at 60 min after clamping No. of dogs Normal Paralysis Paraplegia
Group A >50% 5 5 0 0
<50% 5 1 2 2
Group B >50% 7 7 0 0
<50% 3 1 1 1
Group C >50% 9 9 0 0
<50% 1 0 1 0
·
.:.
costal arteries using extracorporeal circulation.13
Postoperative paraplegia and paralysis occurred in
one of six patients treated with only partial extracor-
poreal circulation. However, after we introduced the
current selective blood perfusion method, the fre-
quency of postoperative paraplegia occurred in only
1 of 11 patients.
Another important problem is the reliability of
determining the intraoperative ischemia. The final
determination can be made only with postoperative
neurologic examinations, and no intraoperative
method of determination during aortic clamping has
been established. In various studies, SESP measure-
ment was reported to be reliable and relatively insen-
sitive to anesthesia.12,14 This method has been inves-
tigated in the orthopedic and neurosurgical fields
since 1972.15 The absence of a change in the SESP
amplitude is thought to indicate the prevention of
postoperative paraplegia; however, low-voltage
SESP does not always signify postoperative paraple-
gia. Clinically, we noted that some dogs with
reduced intraoperative SESP did not develop any
paralysis after the operation. In this study, the para-
plegia was assessed perioperatively; however, when
high-voltage SESP is observed, paraplegia does not
occur. In this study, the specificity of SESP was
100%, but the sensitivity was 78% (Table III). 
We investigated a new direct method of inter-
costal arterial perfusion as a means of spinal cord pro-
tection. Ketamine appears to have some protective
effects against an acute ischemic insult11 in a study in
which the amount of ketamine was reported to be 40
mg/kg. In our study, only 1 mg/kg ketamine was
used for the introduction of anesthesia, and the
amount was too small to protect the spinal cord.11
Furthermore, the blood sugar level and body tem-
perature were maintained within the normal range.
A similar intercostal arterial perfusion method
using cooled saline or blood was reported by Coles
et al.16 and Colon et al.17 Perfusion cooling of the
spinal cord resulted in more rapid extinction of the
evoked response after aortic occlusion compared
with that observed during normothermic ischemia.
Hypothermic regional perfusion is reported to be an
effective technique for protecting the spinal cord
during ischemia. However, due to cooling, the SESP
invariably decreases intraoperatively.
In the current study, we administered PGE1 in
blood at a physiologic temperature. PGE1 has cyto-
protective and vasodilative effects. It relaxes the vas-
cular smooth muscles and limits platelet aggregation
and neutrophil adherence. Furthermore, PGE1 stabi-
lizes cell and lysosomal membranes. In the hepatic
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cells, PGE1 has been reported to reduce the produc-
tion of the cell-damaging factors by macrophages
and Kupffer cells. The same property was reported in
the cells of the brain and in ischemic myocardial cells. 
PGE1 seems to be a promising agent for decreas-
ing the risk of paraplegia.18,19 Grabitz et al.6 found
that intravenous PGE1 administration at the rate of
100 ng/kg/min before, during, and after aortic
clamping was effective for spinal cord protection.
However, intravenous administration requires a
greater amount of PGE1 than does arterial infusion.
PGE1 is a potent vasodilator, and the administration
at 100 ng/kg/min may cause hypotension.20 In this
study, we added PGE1 to the oxygenated blood, and
we selected the dosage based on the backflow rate.
The selective infusion at a low dosage (25 or 50
ng/kg/min) was performed only during aortic
clamping. In groups B and C, there was no signifi-
cant decrease in the systolic blood pressure. In
groups A and B, however, the SESP during clamp-
ing and after declamping was lower than that before
clamping. Only in group C did the SESP after
declamping remain at the same level as that before
clamping. Group C showed the lowest frequency of
neurologic deficit. PGE1 administration at 50
ng/kg/min provided spinal protection against
ischemia without a decrease in systemic blood 
pressure. 
In conclusion, we consider the technique of
regional administration of oxygenated blood con-
taining low-dose PGE1 during aortic clamping to be
clinically feasible, and this technique may reduce the
development of paraplegia. Further studies are need-
ed to determine the optimum PGE1 dosage to pro-
vide maximal protection, as well as the total duration
of ischemia against which the effects of such an infu-
sion remain protective.
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